Reuters: Health
Roche's Tecentriq immunotherapy mixed with the older cancer drug Avastin lifted both overall survival and progression-free survival in people with liver cancer that cannot be surgically removed, the Swiss drugmaker said on Monday.
Roche immunotherapy cocktail boosts survival in liver cancer
Roche immunotherapy cocktail boosts survival in liver cancer
Reuters: Health
Roche's Tecentriq immunotherapy mixed with the older cancer drug Avastin lifted both overall survival and progression-free survival in people with liver cancer that cannot be surgically removed, the Swiss drugmaker said on Monday.
Reuters: Health
Roche's Tecentriq immunotherapy mixed with the older cancer drug Avastin lifted both overall survival and progression-free survival in people with liver cancer that cannot be surgically removed, the Swiss drugmaker said on Monday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment